• 1. The reaction of prop-2-ynylsulfonium salts and sulfonyl-protected β-amino ketones to epoxide-fused 2-methylenepyrrolidines and S-containing pyrroles
  Tingting Jia,Gongruixue Zeng,Chong Zhang,Linghui Zeng,Wenya Zheng,Siyao Li,Keyi Wu,Jiaan Shao,Jiankang Zhang,Huajian Zhu Chem. Commun. 2021 57 2657
• 2. Chemical and spectroscopic properties of the 3-hydroxythiophene [thiophen-3(2H)-one] system
  Gordon A. Hunter,Hamish McNab New J. Chem. 2010 34 2558
• 3. Advances in 1,2,4-triazepines chemistry
  Khaled M. Elattar,Mohamed A. Abozeid,Ibrahim A. Mousa,Ahmed El-Mekabaty RSC Adv. 2015 5 106710
• 4. 3-Hydroxypyrroles and 1H-pyrrol-3(2H)-ones. Part 11. 1H and 13C NMR spectra of 1-substituted and 1,2-disubstituted 3-hydroxy- and 3-alkoxy-pyrroles
  Hamish McNab,Lilian C. Monahan J. Chem. Soc. Perkin Trans. 2 1991 1999
• 5. 777. The preparation and structure of some derivatives of 3-hydroxypyrrole
  J. Davoll J. Chem. Soc. 1953 3802

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrroles Substituted pyrroles

Recent Advances in the Study of 1H-Pyrrol-3-ol (CAS: 29212-57-5) in Chemical Biology and Pharmaceutical Research

The compound 1H-Pyrrol-3-ol (CAS: 29212-57-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by its pyrrole ring with a hydroxyl group at the 3-position, serves as a crucial building block for the synthesis of various bioactive molecules. Recent studies have explored its potential as a scaffold for designing novel therapeutic agents, particularly in the areas of oncology, neurology, and infectious diseases.

One of the most notable advancements in the study of 1H-Pyrrol-3-ol is its role in the development of kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 1H-Pyrrol-3-ol exhibit potent inhibitory activity against specific tyrosine kinases implicated in cancer progression. The researchers utilized structure-activity relationship (SAR) analysis to optimize the compound's efficacy, leading to the identification of a lead candidate with promising preclinical results. This finding underscores the potential of 1H-Pyrrol-3-ol as a key pharmacophore in targeted cancer therapies.

In addition to its applications in oncology, 1H-Pyrrol-3-ol has also been investigated for its neuroprotective properties. A recent study in Bioorganic & Medicinal Chemistry Letters reported that certain derivatives of this compound exhibit significant antioxidant and anti-inflammatory effects in neuronal cell models. These properties make 1H-Pyrrol-3-ol a potential candidate for the treatment of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. The study highlighted the compound's ability to modulate oxidative stress pathways, thereby protecting neurons from damage.

Another area of interest is the use of 1H-Pyrrol-3-ol in antimicrobial drug development. Researchers have synthesized a series of analogs with enhanced activity against drug-resistant bacterial strains. A 2024 publication in Antimicrobial Agents and Chemotherapy detailed the synthesis and evaluation of these analogs, revealing their efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and other multidrug-resistant pathogens. The study emphasized the importance of the hydroxyl group in 1H-Pyrrol-3-ol for its antimicrobial activity, providing a foundation for further structural optimization.

Despite these promising developments, challenges remain in the clinical translation of 1H-Pyrrol-3-ol-based therapeutics. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through rigorous preclinical and clinical studies. However, the growing body of research on this compound highlights its potential as a versatile scaffold for drug discovery. Future studies are expected to focus on improving the pharmacokinetic properties of 1H-Pyrrol-3-ol derivatives and exploring their applications in combination therapies.

In conclusion, 1H-Pyrrol-3-ol (CAS: 29212-57-5) represents a promising avenue for innovation in chemical biology and pharmaceutical research. Its diverse biological activities and structural flexibility make it a valuable tool for the development of novel therapeutic agents. As research continues to uncover its full potential, this compound is likely to play an increasingly important role in addressing unmet medical needs across various disease areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)